Search Results - "Maksymiuk, A."

Refine Results
  1. 1

    A wearable activity tracker intervention for promoting physical activity in adolescents with juvenile idiopathic arthritis: a pilot study by Heale, Liane D, Dover, Saunya, Goh, Y Ingrid, Maksymiuk, Victoria A, Wells, Greg D, Feldman, Brian M

    Published in Pediatric rheumatology online journal (22-10-2018)
    “…Children and adolescents with juvenile idiopathic arthritis (JIA) are less physically active than their healthy peers and are at high risk of missing out on…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Significance of Neuron-specific Enolase Levels before and during Therapy for Small Cell Lung Cancer by BONNER, J. A, SLOAN, J. A, MARKS, R. S, PEREZ, E. A, ROWLAND, K. M, KLEE, G. G, KUGLER, J. W, MAILLIARD, J. A, WIESENFELD, M, KROOK, J. E, MAKSYMIUK, A. W, SHAW, E. G

    Published in Clinical cancer research (01-02-2000)
    “…The level of serum neuron-specific enolase (NSE) has been implicated as a prognostic factor for patients with small cell lung cancer (SCLC). A prospective…”
    Get full text
    Journal Article
  4. 4

    Distinct B-cell clonal bands in Helicobacter pylori gastritis with lymphoid hyperplasia by Saxena, Anurag, Moshynska, Oksana, Kanthan, Rani, Bhutani, Mohit, Maksymiuk, Andrew W., Lukie, Bryan E.

    Published in The Journal of pathology (01-01-2000)
    “…Helicobacter pylori (Hp)‐associated gastritis is a risk factor for gastric mucosa‐associated lymphoid tissue (MALT) lymphoma. Clonal B‐cell populations are…”
    Get full text
    Journal Article
  5. 5

    Patients' Perceptions of Physicians' Epistemic Authority When Recommending Flu Inoculation by Bar-Tal, Yoram, Stasiuk, Katarzyna, Maksymiuk, Renata A.

    Published in Health psychology (01-06-2013)
    “…Objective: Patient perception of physician expertise has important implications for adherence to treatment. This study investigates factors that may influence…”
    Get full text
    Journal Article
  6. 6

    Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial by Morton, R F, Jett, J R, McGinnis, W L, Earle, J D, Therneau, T M, Krook, J E, Elliott, T E, Mailliard, J A, Nelimark, R A, Maksymiuk, A W

    Published in Annals of internal medicine (01-11-1991)
    “…To compare the survival of patients with medically inoperable or unresectable stage III non-small cell lung cancer treated with thoracic radiotherapy alone or…”
    Get more information
    Journal Article
  7. 7

    Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer by Loprinzi, C L, Goldberg, R M, Su, J Q, Mailliard, J A, Kuross, S A, Maksymiuk, A W, Kugler, J W, Jett, J R, Ghosh, C, Pfeifle, D M

    Published in Journal of clinical oncology (01-06-1994)
    “…Hydrazine sulfate, an agent that appears to inhibit gluconeogenesis, has been studied in cancer patients for approximately 20 years. There was a recent…”
    Get more information
    Journal Article
  8. 8

    Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer by Jett, J R, Maksymiuk, A W, Su, J Q, Mailliard, J A, Krook, J E, Tschetter, L K, Kardinal, C G, Twito, D I, Levitt, R, Gerstner, J B

    Published in Journal of clinical oncology (01-11-1994)
    “…We evaluated the effect of recombinant interferon gamma (rIFN-gamma) on survival and toxicity in small-cell lung cancer (SCLC) patients in complete remission…”
    Get more information
    Journal Article
  9. 9

    Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial by Maksymiuk, A W, Jett, J R, Earle, J D, Su, J Q, Diegert, F A, Mailliard, J A, Kardinal, C G, Krook, J E, Veeder, M H, Wiesenfeld, M

    Published in Journal of clinical oncology (01-01-1994)
    “…The combination of etoposide (E) and cisplatin (P) is an accepted standard therapy for small-cell lung cancer (SCLC); however, the optimal sequencing and…”
    Get more information
    Journal Article
  10. 10

    Systemic candidiasis in cancer patients by Maksymiuk, A W, Thongprasert, S, Hopfer, R, Luna, M, Fainstein, V, Bodey, G P

    Published in The American journal of medicine (30-10-1984)
    “…Two hundred thirty-five fungal infections occurred in patients with malignant diseases over a four-year period. One hundred eighty-eight were due to Candida…”
    Get more information
    Journal Article
  11. 11

    Paclitaxel Premedication Regimens by BOEHM, DARRYL K., MAKSYMIUK, ANDREW W.

    “…Hypersensitivity reactions (HSRs) have been a problem associated with the administration of paclitaxel. Reduced doses of dexamethasone could be used from the…”
    Get full text
    Journal Article
  12. 12

    Phase II trial of topotecan for the treatment of mesothelioma by MAKSYMIUK, A. W, MARSCHKE, R. F, TAZELAAR, H. D, GRILL, J, NAIR, S, MARKS, R. S, BROOKS, B. J, MAILLIARD, J. A, BURTON, G. M, JETT, J. R

    Published in American journal of clinical oncology (01-12-1998)
    “…The North Central Cancer Treatment Group designed a phase II trial to assess the efficacy and toxicity of topotecan in patients with unresectable malignant…”
    Get full text
    Journal Article
  13. 13

    Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases by Shaw, E G, Su, J Q, Eagan, R T, Jett, J R, Maksymiuk, A W, Deigert, F A

    Published in Journal of clinical oncology (01-11-1994)
    “…To determine whether prophylactic cranial irradiation (PCI) has an impact on brain failure and survival in patients with small-cell lung cancer (SCLC) who have…”
    Get more information
    Journal Article
  14. 14

    Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer : the Canadian experience by LATREILLE, J, GELMON, K. A, HIRSH, V, LABERGE, F, MAKSYMIUK, A. W, SHEPHERD, F. A, DELORME, F, BERILLE, J

    Published in Investigational new drugs (01-01-1998)
    “…We performed a Phase II trial to evaluate the activity and tolerability of docetaxel as a single agent in the treatment of advanced non-small cell lung cancer…”
    Get full text
    Journal Article
  15. 15

    Interferon instillation for malignant pleural effusions by Goldman, C A, Skinnider, L F, Maksymiuk, A W

    Published in Annals of oncology (01-02-1993)
    “…Malignant pleural effusions can be managed in various ways including instillation of antineoplastic agents. Instillations of alfa interferon-2b (IFN-alpha 2b)…”
    Get more information
    Journal Article
  16. 16

    Monosaccharides in the water of the Gulf of Gdansk by Waldemar Grzybowski, Agnieszka Maksymiuk

    Published in Oceanologia (2001)
    “…The concentration of monosaccharides in samples collected in the Gulf of Gdansk area was determined in water filtered through ~0.8 µm pore size filters…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Non-Hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience by Maksymiuk, A W, Bratvold, J S, Ezzat, W, Tan, L K, Skinnider, L F

    Published in Cancer (01-02-1994)
    “…The incidence and treatment of non-Hodgkin's lymphoma (NHL) have changed in recent years. This study was intended to compare current features with a previous…”
    Get more information
    Journal Article
  19. 19

    Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients by FAINSTEIN, V, BODEY, G. P, ELTING, L, MAKSYMIUK, A, KEATING, M, MCCREDIE, K. B

    Published in Antimicrobial Agents and Chemotherapy (01-01-1987)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  20. 20

    Autologous human B-cell immune response to pulmonary adenocarcinomatous polymorphic epithelial mucin by XIANG, J, MOYANA, T, MAKSYMIUK, A

    Published in Journal of clinical immunology (01-03-1995)
    “…In order to investigate whether a B-cell immune response to the polymorphic epithelial mucin (PEM) is present in adenocarcinomatous patients, peripheral blood…”
    Get full text
    Journal Article